These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 16704920)
21. The Th1-promoting effects of dehydroepiandrosterone can provide an explanation for the stronger Th1-immune response of women. Namazi MR Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):65-9. PubMed ID: 19279363 [TBL] [Abstract][Full Text] [Related]
22. Outcomes in Children Born to Women with Rheumatic Diseases. Vinet É; Bernatsky S Rheum Dis Clin North Am; 2017 May; 43(2):263-273. PubMed ID: 28390568 [TBL] [Abstract][Full Text] [Related]
23. Minocycline induced autoimmune disease in rheumatoid arthritis: a missed diagnosis? Marzo-Ortega H; Misbah S; Emery P J Rheumatol; 2001 Feb; 28(2):377-8. PubMed ID: 11246682 [TBL] [Abstract][Full Text] [Related]
24. Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis. Wahle M; Hanefeld G; Brunn S; Straub RH; Wagner U; Krause A; Häntzschel H; Baerwald CG Arthritis Res Ther; 2006; 8(5):R138. PubMed ID: 16889669 [TBL] [Abstract][Full Text] [Related]
25. Low levels of Th1-type cytokines and increased levels of Th2-type cytokines in kidney transplant recipients with active cytomegalovirus infection. Essa S; Pacsa A; Raghupathy R; Said T; Nampoory MR; Johny KV; Al-Nakib W Transplant Proc; 2009 Jun; 41(5):1643-7. PubMed ID: 19545699 [TBL] [Abstract][Full Text] [Related]
26. Maternal circulating interferon-gamma and interleukin-6 as biomarkers of Th1/Th2 immune status throughout pregnancy. Aris A; Lambert F; Bessette P; Moutquin JM J Obstet Gynaecol Res; 2008 Feb; 34(1):7-11. PubMed ID: 18226122 [TBL] [Abstract][Full Text] [Related]
28. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production. Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH Life Sci; 2007 Oct; 81(19-20):1403-10. PubMed ID: 17950363 [TBL] [Abstract][Full Text] [Related]
29. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Eisenberg R; Albert D Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648 [TBL] [Abstract][Full Text] [Related]
30. Possible role of adipokines in systemic lupus erythematosus and rheumatoid arthritis. Barbosa Vde S; Rêgo J; Antônio da Silva N Rev Bras Reumatol; 2012; 52(2):278-87. PubMed ID: 22460416 [TBL] [Abstract][Full Text] [Related]
31. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ostensen M Ann N Y Acad Sci; 1999 Jun; 876():131-43; discussion 144. PubMed ID: 10415601 [TBL] [Abstract][Full Text] [Related]
32. Cord blood cytokines and chemokines and development of allergic disease. Sandberg M; Frykman A; Ernerudh J; Berg G; Matthiesen L; Ekerfelt C; Nilsson LJ; Jenmalm MC Pediatr Allergy Immunol; 2009 Sep; 20(6):519-27. PubMed ID: 19175890 [TBL] [Abstract][Full Text] [Related]
33. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776 [TBL] [Abstract][Full Text] [Related]
34. Relationship of Th1/Th2 cell balance with the immune response to influenza vaccine during pregnancy. Yamaguchi K; Hisano M; Isojima S; Irie S; Arata N; Watanabe N; Kubo T; Kato T; Murashima A J Med Virol; 2009 Nov; 81(11):1923-8. PubMed ID: 19774681 [TBL] [Abstract][Full Text] [Related]
35. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Costedoat-Chalumeau N; Amoura Z; Huong DL; Lechat P; Piette JC Autoimmun Rev; 2005 Feb; 4(2):111-5. PubMed ID: 15722258 [TBL] [Abstract][Full Text] [Related]
36. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice]. Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365 [TBL] [Abstract][Full Text] [Related]
37. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines. Song X; Liang F; Liu N; Luo Y; Xue H; Yuan F; Tan L; Sun Y; Xi C; Xi Y Vaccine; 2009 Jan; 27(5):690-700. PubMed ID: 19095031 [TBL] [Abstract][Full Text] [Related]
38. Identification of regulatory T cells in systemic lupus erythematosus. Gerli R; Nocentini G; Alunno A; Bocci EB; Bianchini R; Bistoni O; Riccardi C Autoimmun Rev; 2009 Mar; 8(5):426-30. PubMed ID: 19185065 [TBL] [Abstract][Full Text] [Related]
39. Managing contraception and pregnancy in the rheumatologic diseases. Clowse ME Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):373-85. PubMed ID: 20534371 [TBL] [Abstract][Full Text] [Related]